Recombinant CD23 (Lumiliximab Biosimilar) antibody

Catalog No. ABIN7814062

This Chimeric Chimeric antibody specifically detects CD23 (Lumiliximab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant CD23 (Lumiliximab Biosimilar) antibody (ABIN7814062)

Target: CD23 (Lumiliximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Lumiliximab Biosimilar - Anti-CD23,FCER2 mAb - Research Grade

Characteristics: IgG1-kappa

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4.

Handling Advice: Avoid repeated freeze-thaw cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles

Expiry Date: 12 months

Target Details

Target: CD23 (Lumiliximab Biosimilar)

Alternative Name: Lumiliximab Biosimilar

Target Type: Biosimilar

Background: Anti-CD23, Anti-FCER2, Anti-IGEBF, IDEC-152, P5E8,

UniProt: P06734

CAS-No: CAS: 357613-86-6